Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1a,Condition 1b,Condition 1c,Condition 2a,Condition 2b,Condition 2c 736,"Kitada K, et al., PLoS One. 2012;7(7):e41896. Epub 2012 Jul 24.",blood aldosterone amount,,RS:0003328,SS/NEisSlc,male,42 days,4,,CMO:0000551,plasma aldosterone level,,,,139.3,pg/ml,22.8,45.6,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled sodium content diet (8 %) ,67280,controlled sodium content diet (8 %) ,,,,, 736,"Kitada K, et al., PLoS One. 2012;7(7):e41896. Epub 2012 Jul 24.",blood aldosterone amount,,RS:0003328,SS/NEisSlc,male,70 days,4,,CMO:0000551,plasma aldosterone level,,,,98.8,pg/ml,15.9,31.8,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled sodium content diet (8 %) (for 28 days),67281,controlled sodium content diet (8 %) (for 28 days),,,,, 736,"Kitada K, et al., PLoS One. 2012;7(7):e41896. Epub 2012 Jul 24.",blood aldosterone amount,,RS:0003328,SS/NEisSlc,male,42 days,4,,CMO:0000551,plasma aldosterone level,,,,157.3,pg/ml,45.2,90.4,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled sodium content diet (8 %) and controlled tempol content drinking water (0.5 mmol/l) ,69654,controlled sodium content diet (8 %) ,controlled tempol content drinking water (0.5 mmol/l) ,,,, 736,"Kitada K, et al., PLoS One. 2012;7(7):e41896. Epub 2012 Jul 24.",blood aldosterone amount,,RS:0003328,SS/NEisSlc,male,70 days,4,,CMO:0000551,plasma aldosterone level,,,,57.3,pg/ml,18.1,36.2,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled sodium content diet (8 %) (for 28 days) and controlled tempol content drinking water (0.5 mmol/l) (for 28 days),69655,controlled sodium content diet (8 %) (for 28 days),controlled tempol content drinking water (0.5 mmol/l) (for 28 days),,,, 736,"Kitada K, et al., PLoS One. 2012;7(7):e41896. Epub 2012 Jul 24.",blood aldosterone amount,,RS:0003328,SS/NEisSlc,male,77 days,4,,CMO:0000551,plasma aldosterone level,,,,293.8,pg/ml,39.4,78.8,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled sodium content diet (8 %) (for 7 days) then controlled sodium content diet (0.3 %) (for 7 days),69656,controlled sodium content diet (8 %) (for 7 days),,,controlled sodium content diet (0.3 %) (for 7 days),, 736,"Kitada K, et al., PLoS One. 2012;7(7):e41896. Epub 2012 Jul 24.",blood aldosterone amount,,RS:0003328,SS/NEisSlc,male,98 days,4,,CMO:0000551,plasma aldosterone level,,,,295,pg/ml,54.3,108.6,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled sodium content diet (8 %) (for 28 days) then controlled sodium content diet (0.3 %) (for 28 days),69657,controlled sodium content diet (8 %) (for 28 days),,,controlled sodium content diet (0.3 %) (for 28 days),, 736,"Kitada K, et al., PLoS One. 2012;7(7):e41896. Epub 2012 Jul 24.",blood aldosterone amount,,RS:0003328,SS/NEisSlc,male,77 days,4,,CMO:0000551,plasma aldosterone level,,,,215,pg/ml,35.7,71.4,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled sodium content diet (8 %) (for 28 days) and controlled tempol content drinking water (0.5 mmol/l) (for 28 days) then controlled sodium content diet (0.3 %) (for 7 days),69658,controlled sodium content diet (8 %) (for 28 days),controlled tempol content drinking water (0.5 mmol/l) (for 28 days),,controlled sodium content diet (0.3 %) (for 7 days),, 736,"Kitada K, et al., PLoS One. 2012;7(7):e41896. Epub 2012 Jul 24.",blood aldosterone amount,,RS:0003328,SS/NEisSlc,male,98 days,4,,CMO:0000551,plasma aldosterone level,,,,327.5,pg/ml,46.4,92.8,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled sodium content diet (8 %) (for 28 days) and controlled tempol content drinking water (0.5 mmol/l) (for 28 days) then controlled sodium content diet (0.3 %) (for 28 days),69659,controlled sodium content diet (8 %) (for 28 days),controlled tempol content drinking water (0.5 mmol/l) (for 28 days),,controlled sodium content diet (0.3 %) (for 28 days),, 2583,"Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9.",blood aldosterone amount,,RS:0000752,SHR/NCrlCrlj,male,126 days,5,,CMO:0000551,plasma aldosterone level,,,,389,pg/ml,86.0,192.3018,MMO:0000313,plasma aldosterone analysis,,0.0,,unx,42,days,unilateral nephrectomy (for 42 days),101266,unilateral nephrectomy (for 42 days),,,,, 2583,"Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9.",blood aldosterone amount,,RS:0000752,SHR/NCrlCrlj,male,126 days,8,,CMO:0000551,plasma aldosterone level,,,,492,pg/ml,46.0,130.1076,MMO:0000313,plasma aldosterone analysis,,0.0,,unx,42,days,unilateral nephrectomy (for 42 days) then controlled candesartan content drinking water (1 mg/kg/d) (for 28 days),101267,unilateral nephrectomy (for 42 days),,,controlled candesartan content drinking water (1 mg/kg/d) (for 28 days),, 2583,"Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9.",blood aldosterone amount,,RS:0000752,SHR/NCrlCrlj,male,126 days,9,,CMO:0000551,plasma aldosterone level,,,,369,pg/ml,54.0,162.0,MMO:0000313,plasma aldosterone analysis,,0.0,,unx,42,days,unilateral nephrectomy (for 42 days) then controlled delapril content drinking water (30 mg/kg/d) (for 28 days),101268,unilateral nephrectomy (for 42 days),,,controlled delapril content drinking water (30 mg/kg/d) (for 28 days),, 2583,"Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9.",blood aldosterone amount,,RS:0000752,SHR/NCrlCrlj,male,126 days,5,,CMO:0000551,plasma aldosterone level,,,,581,pg/ml,92.0,205.7183,MMO:0000313,plasma aldosterone analysis,,0.0,,unx,42,days,unilateral nephrectomy (for 42 days) then controlled hydralazine content drinking water (15 mg/kg/d) (for 28 days),101269,unilateral nephrectomy (for 42 days),,,controlled hydralazine content drinking water (15 mg/kg/d) (for 28 days),, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",blood aldosterone amount,,RS:0000681,SD,male,0 days,6,,CMO:0000551,plasma aldosterone level,,,,50,pg/ml,4.899,12.0,MMO:0000313,plasma aldosterone analysis,,0.0,,sham unx,13,days,sham surgical control condition (between 12 and 14 days),101555,sham surgical control condition (between 12 and 14 days),,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",blood aldosterone amount,,RS:0000681,SD,male,0 days,11,,CMO:0000551,plasma aldosterone level,,-,,526,pg/ml,78.3929,260.0,MMO:0000313,plasma aldosterone analysis,,0.0,,unx,13,days,unilateral nephrectomy (between 12 and 14 days),101556,unilateral nephrectomy (between 12 and 14 days),,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",blood aldosterone amount,,RS:0000681,SD,male,0 days,5,,CMO:0000551,plasma aldosterone level,,,,181,pg/ml,55.4545,124.0,MMO:0000313,plasma aldosterone analysis,,0.0,,unx,13,days,unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days),101557,unilateral nephrectomy (between 12 and 14 days),,,enalapril (50 mg/l) (between 12 and 14 days),losartan (180 mg/l) (between 12 and 14 days), 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",blood aldosterone amount,,RS:0000681,SD,male,0 days,5,,CMO:0000551,plasma aldosterone level,,,,487,pg/ml,50.9823,114.0,MMO:0000313,plasma aldosterone analysis,,0.0,,unx,13,days,unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days),101558,unilateral nephrectomy (between 12 and 14 days),,,enalapril (50 mg/l) (between 12 and 14 days),losartan (180 mg/l) (between 12 and 14 days),aldosterone (30-40 mg/kg/d) (between 12 and 14 days) 3100,"Willette RN, etal., J Cardiovasc Pharmacol. 2001 Oct;38(4):606-17. doi: 10.1097/00005344-200110000-00013.",blood aldosterone amount,,RS:0000775,SHRSP/A3N,male,210 days to 182 days,8,,CMO:0000551,plasma aldosterone level,,,,151,pg/ml,27.0,76.3675,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 112 days) and controlled fat content diet (24.5 %) (for 112 days) and controlled enrasentan content diet (2400 ppm) (for 112 days),107940,controlled sodium chloride content drinking water (1 %) (for 112 days),controlled fat content diet (24.5 %) (for 112 days),controlled enrasentan content diet (2400 ppm) (for 112 days),,, 3100,"Willette RN, etal., J Cardiovasc Pharmacol. 2001 Oct;38(4):606-17. doi: 10.1097/00005344-200110000-00013.",blood aldosterone amount,,RS:0000775,SHRSP/A3N,male,210 days to 182 days,8,,CMO:0000551,plasma aldosterone level,,,,178,pg/ml,12.0,33.9411,MMO:0000073,radioimmunoassay,,0.0,,,,,control condition,107937,control condition,,,,, 3100,"Willette RN, etal., J Cardiovasc Pharmacol. 2001 Oct;38(4):606-17. doi: 10.1097/00005344-200110000-00013.",blood aldosterone amount,,RS:0000775,SHRSP/A3N,male,210 days to 182 days,8,,CMO:0000551,plasma aldosterone level,,,,347,pg/ml,72.0,203.6468,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled sodium content drinking water (1 %) (for 112 days) and controlled fat content diet (24.5 %) (for 112 days),107938,controlled sodium content drinking water (1 %) (for 112 days),controlled fat content diet (24.5 %) (for 112 days),,,, 3100,"Willette RN, etal., J Cardiovasc Pharmacol. 2001 Oct;38(4):606-17. doi: 10.1097/00005344-200110000-00013.",blood aldosterone amount,,RS:0000775,SHRSP/A3N,male,210 days to 182 days,8,,CMO:0000551,plasma aldosterone level,,,,146,pg/ml,26.0,73.5391,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 112 days) and controlled fat content diet (24.5 %) (for 112 days) and controlled enrasentan content diet (1200 ppm) (for 112 days),107939,controlled sodium chloride content drinking water (1 %) (for 112 days),controlled fat content diet (24.5 %) (for 112 days),controlled enrasentan content diet (1200 ppm) (for 112 days),,, 2218,"Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3.",blood aldosterone amount,,RS:0000742,WKY,male,112 days,5,,CMO:0000551,plasma aldosterone level,,,,470,pg/ml,8.0,17.8885,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled in utero environment (100 % of calories) (for 22 days),101691,controlled in utero environment (100 % of calories) (for 22 days),,,,, 2218,"Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3.",blood aldosterone amount,,RS:0000742,WKY,male,112 days,6,,CMO:0000551,plasma aldosterone level,,,,1130,pg/ml,240.0,587.8775,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled in utero environment (30 % of calories) (for 22 days),101692,controlled in utero environment (30 % of calories) (for 22 days),,,,, 2926,"Capasso G, et al., Am J Physiol Renal Physiol. 2005 Jun;288(6):F1173-82. doi: 10.1152/ajprenal.00228.2004. Epub 2005 Feb 1.",blood aldosterone amount,,RS:0000580,MNS,not specified,25 days to 23 days,11,,CMO:0000551,plasma aldosterone level,,,,118,pg/ml,44.0,145.9315,MMO:0000073,radioimmunoassay,,0.0,,,,,control condition,104166,control condition,,,,, 2926,"Capasso G, et al., Am J Physiol Renal Physiol. 2005 Jun;288(6):F1173-82. doi: 10.1152/ajprenal.00228.2004. Epub 2005 Feb 1.",blood aldosterone amount,,RS:0000577,MHS,not specified,25 days to 23 days,11,,CMO:0000551,plasma aldosterone level,,,,150,pg/ml,30.0,99.4987,MMO:0000073,radioimmunoassay,,0.0,,,,,control condition,104167,control condition,,,,, 3164,"Capasso G, etal., Am J Physiol Renal Physiol. 2008 Aug;295(2):F556-67. doi: 10.1152/ajprenal.00340.2007. Epub 2008 May 14.",blood aldosterone amount,,RS:0000580,MNS,not specified,87 days to 85 days,11,,CMO:0000551,plasma aldosterone level,,,,69,pg/ml,26.0,86.2322,MMO:0000073,radioimmunoassay,,0.0,,,,,control condition,110156,control condition,,,,, 3164,"Capasso G, etal., Am J Physiol Renal Physiol. 2008 Aug;295(2):F556-67. doi: 10.1152/ajprenal.00340.2007. Epub 2008 May 14.",blood aldosterone amount,,RS:0000577,MHS,not specified,87 days to 85 days,11,,CMO:0000551,plasma aldosterone level,,,,397,pg/ml,50.0,165.8312,MMO:0000073,radioimmunoassay,,0.0,,,,,control condition,110157,control condition,,,,,